For each of the following patients presenting with clinical and biochemical evidence of hepatic injury, select the most appropriate confirmatory or highly specific diagnostic laboratory evaluation.
- A 34-year-old man presents with progressive resting tremor, dysarthria, and behavioral changes. Hepatic panel reveals an aspartate aminotransferase of 85 U/L and an alanine aminotransferase of 92 U/L.Serum ceruloplasmin level and 24-hour urinary copper excretion
- A 51-year-old woman describes three months of debilitating fatigue and severe generalized pruritus. Her alkaline phosphatase is 410 U/L with normal transaminases. Abdominal ultrasound shows no biliary dilation.Antimitochondrial antibody (AMA) titer
- A 29-year-old primigravida at 34 weeks gestation develops intense nighttime itching predominantly on her palms and soles. Laboratory testing shows mildly elevated transaminases with a normal gamma-glutamyl transferase.Fasting serum total bile acid concentration
- A 45-year-old man with type 2 diabetes mellitus presents with new-onset symmetric arthralgias in his second and third metacarpophalangeal joints. Hepatic panel reveals an alanine aminotransferase of 115 U/L.Serum transferrin saturation and ferritin levels
- A 38-year-old woman with a history of hypothyroidism presents with acute-onset jaundice and fatigue. Laboratory evaluation shows an aspartate aminotransferase of 580 U/L, alanine aminotransferase of 640 U/L, and hypergammaglobulinemia.Anti-smooth muscle antibody and anti-liver/kidney microsomal type 1 antibody assays
Cevap
Each patient's unique demographic profile, symptom cluster, and initial hepatic panel pattern dictates a highly specific targeted laboratory evaluation: copper studies for Wilson disease, AMA for primary biliary cholangitis, bile acids for intrahepatic cholestasis of pregnancy, iron studies for hemochromatosis, and ASMA/anti-LKM1 for autoimmune hepatitis.
Each clinical scenario provides cardinal demographic features, extrahepatic manifestations, and initial biochemical patterns (hepatocellular vs. cholestatic) that narrow the differential diagnosis to a single leading etiology. Selecting the precise targeted laboratory test prevents unnecessary invasive procedures, limits diagnostic cost, and expedites definitive management.
Adım Adım Çözüm
Anahtar Kavram
Targeted Diagnostic Laboratory Sequencing for Hepatic Pathology
Tahmini Süre:2m 0s